Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COIN: Continuous vs Intermittent Chemo +/- Cetuximab in mCRC
NCT00182715Phase 3Unknown
- Sponsor
- Velindre University NHS Trust
- Start
- Mar 2005
- Primary completion
- May 2009
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of cetuximab in metastatic colorectal cancer (mCRC), sponsored by Velindre University NHS Trust. Status: unknown.
02
Drugs
cetuximab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00182715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182715.